Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
2
×
national top stories
alexion pharmaceuticals
alnylam pharmaceuticals
boehringer ingelheim
boston
cancer
cancer drugs
colorectal cancer
deals
dicerna pharamceuticals
fda
hepatitis b
hepatitis b virus
hereditary transthyretin amyloidosis
ipo
mark goldsmith
non-small cell lung cancer
pancreatic cancer
patisiran
ras
revolution medicines
rna interference
roche
san francisco
san francisco blog main
san francisco top stories
sanofi
the column group
third rock ventures
university of illinois at urbana-champaign
warp drive bio
world health organization
What
disease
2
×
medicines
research
2
×
cancer
cancer’s
caught
causing
dicerna
drug
eye
frontiers
gene
hepatitis
intended
ipo
known
maps
parlance
pay
pharma
pharmaceutical
pharmaceuticals
play
producing
protein
proteins
reach
revealed
revolution
roche
role
stop
stopping
team
way
Language
unset
Current search:
disease
×
research
×
" national blog main "
×
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug